Brand name and classification principles: repacked pure water and diagnostic kits were treated according to essential character and tariff headings.

Repacking and labelling bulk demineralised water as "Pure Water" did not change its essential character, and the expression described the goods rather than a proprietary brand name; on that reasoning, the product was not treated as a branded commodity under Chapter 22. Diagnostic reagent kits such as the "WIDAL-SALMONELLA ANIGENS KIT" were held to fall under heading 30.02, with heading 38.22 excluded where goods answer to heading 30.02 under the HSN notes. The commentary also records that the later Supreme Court view on this classification issue prevailed over the contrary revenue position.

---

---

Issues: (i) Whether repacking and labelling of bulk demineralised water as "Pure Water" amounted to manufacture and whether the expression "Pure Water" constituted a brand name so as to attract duty under Chapter 22. (ii) Whether "WIDAL-SALMONELLA ANIGENS KIT" was classifiable under heading 30.02 as claimed by the assessee or under heading 38.22 as held by the authorities below.

Issue (i): Whether repacking and labelling of bulk demineralised water as "Pure Water" amounted to manufacture and whether the expression "Pure Water" constituted a brand name so as to attract duty under Chapter 22.

Analysis: The product purchased in bulk was already described as pure water and its repacking into smaller containers did not change its essential character. The expression "Pure Water" described the goods themselves and was not shown to be a registered or proprietary brand name. In the absence of evidence that the label belonged to any person as a brand, the departmental view that the repacked product became a distinct branded commodity was not sustainable.

Conclusion: The product remained classifiable as pure water and did not become a branded product by reason of repacking or labelling. The classification adopted by the authorities below was set aside and the assessee succeeded on this issue.

Issue (ii): Whether "WIDAL-SALMONELLA ANIGENS KIT" was classifiable under heading 30.02 as claimed by the assessee or under heading 38.22 as held by the authorities below.

Analysis: The product was a diagnostic reagent kit based on agglutination and fell within the scope of diagnostic kits covered under heading 30.02. The HSN notes for heading 38.22 exclude goods classifiable under heading 30.02. The classification dispute was governed by the principle that antisera and similar blood fractions, including diagnostic uses, stand excluded from heading 38.22 where they answer to heading 30.02. The prior contrary view relied on by the revenue did not prevail in light of the later Supreme Court ruling on the same classification issue.

Conclusion: The kit was correctly classifiable under heading 30.02 and not under heading 38.22. The assessee succeeded on this issue as well.

Final Conclusion: Both disputed classifications were decided in favour of the assessee, the duty demands did not survive, and the appeals were allowed with consequential relief.

Ratio Decidendi: A product does not become a branded or differently classifiable commodity merely because it is repacked if its essential character and commercial identity remain unchanged, and diagnostic reagent kits that answer to heading 30.02 are excluded from classification under heading 38.22.

---